6
©2012 closerlook, inc. closerlook.com SXSW 2013 Interactive Panel Submission Tummy Trends Mobile App

Sxsw interactive panel2013_closerlook_tummytrends_00a

Embed Size (px)

Citation preview

Page 1: Sxsw interactive panel2013_closerlook_tummytrends_00a

©2012 closerlook, inc. closerlook.com

SXSW2013 Interactive Panel Submission Tummy Trends Mobile App

Page 2: Sxsw interactive panel2013_closerlook_tummytrends_00a

SXSW / 2013 Interactive Panel Submission / Tummy Trends Mobile App

©2012 closerlook, inc. closerlook.com

Tummy Trends Mobile AppAMITIZA, a product of Takeda Pharmaceuticals U.S.A., Inc., is indicated for Chronic Idiopathic Constipation (CIC) in adults and Irritable Bowel Syndrome with Constipation (IBS-C) in women. Because the symptoms of constipation and IBS are chronic and ever changing, patients can have difficulty tracking symptoms over time and accurately explaining them to their healthcare professionals (HCPs). As a result, there is high potential for patient–HCP miscommunication, which can impede the HCP’s ability to properly treat these conditions and know whether a prescription treatment like AMITIZA may be beneficial. closerlook, inc. recommended developing a mobile application to help patients monitor their symptoms, treatments and behaviors, and more easily and accurately share them with their HCPs. In order to make the app accessible to as many people as possible, closerlook recommended developing it as an unbranded app and making it available in the Apple iTunes App Store free of charge. The first mobile app effort for Takeda Pharmaceuticals U.S.A., Inc., Tummy Trends is a discreet and convenient patient-helping mobile application designed with a focus on ease of use for constipation and IBS sufferers and their HCPs.

On March 30, 2012, version 1.0 of the Takeda Tummy Trends mobile app, built on the Apple platform for the iPhone and iPod touch, was launched in the iTunes App Store. In its first two weeks in the store, Tummy Trends was already ranked as a five-star app. Tummy Trends is being marketed to HCPs and to patients via print pieces delivered by Takeda Sales Representatives and an e-mail sent to HCPs who have opted in to receive communications from AMITIZA.

Page 3: Sxsw interactive panel2013_closerlook_tummytrends_00a

SXSW / 2013 Interactive Panel Submission / Tummy Trends Mobile App

©2012 closerlook, inc. closerlook.com

Instructions Log an EntryLoading Screen Instructions (continued)

Page 4: Sxsw interactive panel2013_closerlook_tummytrends_00a

SXSW / 2013 Interactive Panel Submission / Tummy Trends Mobile App

©2012 closerlook, inc. closerlook.com

Treatments Entries (List View)Symptoms & BMs Entries (Calendar View)

Page 5: Sxsw interactive panel2013_closerlook_tummytrends_00a

SXSW / 2013 Interactive Panel Submission / Tummy Trends Mobile App

©2012 closerlook, inc. closerlook.com

E-mail to Doctor (Outlook)Report Summary Report Graph Information

Report Graph Information

Page 6: Sxsw interactive panel2013_closerlook_tummytrends_00a

SXSW / 2013 Interactive Panel Submission / Tummy Trends Mobile App

©2012 closerlook, inc. closerlook.com

Chart (BM vs Fiber)

Report Details

Encouragement